Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
11/2004
11/23/2004US6821971 For prophyalxis of rheumatoid arthritis, osteoarthritis, inflammatory bowel disease (ibs), septic shock, cardiopulmonary dysfunction, acute respiratory disease, cachexia
11/23/2004CA2134239C Pretargeting methods and compounds
11/18/2004WO2004099176A1 Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
11/18/2004WO2004099145A2 Phenyl substituted cyclic derivatives
11/18/2004WO2004099105A2 Pesticidal (dihalopropenyl) phenylalkyl substituted benzoxazole and benzothiazole derivatives
11/18/2004WO2004098284A2 Pesticidal (dihalopropenyl)phenylalkyl substituted benzodioxolane and benzodioxole derivatives
11/18/2004WO2004098283A2 Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives
11/18/2004US20040230021 Mono-, oligo- and polymers comprising dithienothiophene and aryl groups
11/18/2004US20040229916 substituted N-(indole-2-carbonyl)amides; antiischemic, anticholesterol, hypoglycemic, hypotensive agents; 5-chloro-1H-indole-2-carboxylic acid-[5-(1,2-dihydroxy-1-methyl-ethyl)-3-ethoxy-pyridin-2-yl]-amide
11/18/2004US20040229895 Tetracyclic benzamide derivatives and methods of use thereof
11/18/2004US20040229882 dipeptide or tripeptide MC-1R and MC-4R agonists
11/18/2004US20040229870 Certain alkylene diamine-substituted heterocycles
11/18/2004US20040229863 Administering 4-amino-azepan-3-one compound for inhibiting cathepsin S
11/18/2004US20040229847 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
11/18/2004US20040229846 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
11/18/2004US20040227128 Alkylenedioxythiophenes and poly(alkylenedioxythiophenes) containing mesogenic groups
11/18/2004DE10319611A1 New conjugates useful as reagents for mass-spectrometric analysis of proteins, comprise a protein-reactive group covalently bound to an affinity ligand or solid phase through a linker
11/18/2004CA2523231A1 Pesticidal (dihalopropenyl) phenylalkyl substituted benzoxazole and benzothiazole derivatives
11/18/2004CA2523191A1 Phenyl substituted cyclic derivatives
11/18/2004CA2523085A1 Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives
11/18/2004CA2522857A1 Pesticidal (dihalopropenyl)phenylalkyl substituted benzodioxolane and benzodioxole derivatives
11/18/2004CA2521700A1 Piperidinyl- and piperazinyl-alkylcarbamate derivatives, preparation and therapeutic application thereof
11/17/2004EP1477486A2 Imides as inhibitors of TNF alpha
11/17/2004EP1477478A2 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses.
11/17/2004EP1476431A1 Tricyclic pyrazole derivatives for the treatment of inflammation
11/17/2004EP1476429A1 Novel pyridine- and quinoline-derivatives
11/17/2004EP1289980B1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/17/2004EP1263727B1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
11/17/2004CN1546472A Pyridyl alkane acid amides as cytostatics and immunosupressives
11/17/2004CN1176088C Method for preparing (3aS,6aR)-1,3-dibenzyl-tetrahydro-1H-thieno[3,4-d]imidazole-2(3H)-one-4-normal pentanoic acid
11/16/2004US6818641 Arthropodicidal carboxanilides
11/16/2004US6818260 Thienothiophene derivatives
11/11/2004WO2004096805A2 Lyotropic liquid crystal systems based on sulfonated perylenetetracarboxylic acid dibenzimidazoles
11/11/2004WO2004096793A1 New alicyclic-amine-substituted 4-carboxamido-benzimidazoles as parp-inhibitors and antioxidants
11/11/2004WO2004096768A1 Anti-diabetic agents
11/11/2004WO2004056879A8 Spirotetrathiocarbamates and spirooxothiocarbamates
11/11/2004US20040225013 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
11/11/2004US20040224994 Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives
11/11/2004US20040224966 Enzyme inhibitors as drugs for cardiovascular disorders, aids, alzheimers disease or urogenital disorders
11/11/2004US20040224960 Pharmaceutical compositions and methods for their use
11/11/2004US20040224951 5,6-Fused uracil derivatives as matrix metalloproteinase inhibitors
11/11/2004US20040224944 Pyrazole compounds useful as protein kinase inhibitors
11/11/2004CA2521962A1 Anti-diabetic agents
11/10/2004EP1474690A1 E2 displacement assay for identifying inhibitors of hpv
11/10/2004EP1474427A1 Polymorphs of clopidogrel hydrochloride and their use as antithrombic compounds
11/10/2004EP1474147A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
11/10/2004EP1259515B1 Thienopyridine derivatives and their use as anti-inflammatory agents
11/10/2004CN1545508A 1,2,4-trioxolane antimalarials
11/10/2004CN1545412A Preventive agent/remedial agent for constipation predominant ibs
11/10/2004CN1545411A Cyclopropyl and cyclobutyl epothilone analogs
11/09/2004US6815460 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors
11/09/2004CA2278139C Novel photochromic heterocyclic fused indenonaphthopyrans
11/04/2004WO2004094433A1 New polymorphs of olanzapine hydrochloride
11/04/2004WO2004094400A2 Substituted benzopyrans as selective estrogen receptor-beta agonists
11/04/2004WO2004094390A1 2-methyl-thieno-benzodiazepine process
11/04/2004WO2004094374A2 Preparation of (s)-clopidogrel and related compounds
11/04/2004WO2004093805A2 Selective spirocyclic glucocorticoid receptor modulators
11/04/2004WO2004087673A3 Migrastatin analogs and uses thereof
11/04/2004WO2004080271A3 Method for prognosticating the progress of breast cancer and compounds useful for prevention or treatment thereof
11/04/2004US20040220404 For therapy of obesity, diabetes, depression, or anxiety in a mammal
11/04/2004US20040220251 Furanose-type bicyclic carbohydrates with biological activity
11/04/2004US20040220229 insulin resistance; central nervous system disorders; vision defects; anticholesterol agents;antilipemic agents; antiischemic agents
11/04/2004US20040220178 Substituted heterocycle fused gamma-carbolines
11/04/2004US20040220173 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders
11/04/2004US20040220169 anticoagulants; factor x inhibitor; N-[1-(5-chloro-1H-benzimidazol-2-yl)ethyl]-3-methyl-4-(2,5-dihydropyrrol-1-ylcarbonyl)benzamide
11/04/2004CA2522946A1 Selective spirocyclic glucocorticoid receptor modulators
11/04/2004CA2518819A1 Substituted benzopyrans as selective estrogen receptor-beta agonists
11/03/2004EP1472536A2 Broad spectrum inhibitors
11/03/2004EP1472260A2 Thieno(3,2-b)pyridones as antiviral compounds
11/03/2004EP1390422B1 Thiophenes and polymers derived therefrom
11/03/2004EP1206452B1 Novel method for preparing benzoperhydroisoindole compounds
11/03/2004CN1543467A Diazacycloalkanes as oxytocin agonists
11/03/2004CN1542011A Sulphur containing heterocyclic and naphthalimides compound and use thereof
11/03/2004CN1173978C Organic electronic material with thiowhorl structure and its preparation method
11/03/2004CN1173977C Process for the production of thienopyrimidine derivatives
11/03/2004CN1173947C 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides
11/02/2004US6812345 Fused pyridine-benzazapine, benzoxepin, or benzothiepin derivatives; hypocholesterolemic and hypolipidemic agents
10/2004
10/28/2004WO2004092182A1 Fragrance compositions comprising benzo[4,5]thieno[3,2-b]pyran-2-one
10/28/2004WO2004092181A1 Heterocyclic mchr1 antagonists
10/28/2004WO2004092158A1 Carboxamide derivatives as anti-diabetic agents
10/28/2004WO2004092156A1 Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists
10/28/2004WO2004092134A1 [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions
10/28/2004WO2004092132A1 [b]-fused bicyclic proline derivatives and their use for treating arthritic conditions
10/28/2004WO2004072085A3 Salt of a sulfonic acid containing clopidogrel and use thereof for the production of pharmaceutical formulations
10/28/2004US20040215019 Substituted isoindoles and the e use thereof
10/28/2004US20040215015 Sulfonated derivatives of perylenetetracarboxylic acid dibenzimidazole sulfoderivatives anisotropic films for liquid crystals
10/28/2004US20040214985 Highly conducting and transparent thin films formed from new fluorinated derivatives of 3,4-ethylenedioxythiophene
10/28/2004US20040214878 Preparation of (s)-clopidogrel and related compounds
10/28/2004US20040214818 Alzheimer's disease; Parkinson's disease; Huntington's disease; cognition activators; learning enhancement; central nervous system disorders
10/28/2004US20040214817 Diaminotriazoles useful as inhibitors of protein kinases
10/28/2004US20040214814 Pyrazole compounds useful as protein kinase inhibitors
10/28/2004CA2522225A1 Carboxamide derivatives as anti-diabetic agents
10/28/2004CA2522195A1 [b]-fused bicyclic proline derivatives and their use for treating arthritic conditions
10/28/2004CA2521832A1 Heterocyclic mchr1 antagonists
10/28/2004CA2521364A1 [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions
10/27/2004EP1470130A2 Crystalline form i of 2-methyl-4-(4-methyl-1-piperazinyl) 10h thieno 2,3-b 1,5 benzodiazepine
10/27/2004EP1470119A1 Benzothiophene compounds having antiinfective activity
10/27/2004EP1469854A1 Condensed heterocyclic compounds
10/27/2004EP1469853A1 Use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno(2,3-d-pyrimidine for treating of urinary incontinence
10/27/2004EP1078261B1 Method for immobilising and self-organizing biological macromolecules on carbon nanotubes and uses